The Next Evolution of TLIF: Where Innovation Meets Clinical Evidence

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 28 Sept, 09:00 UTC

New evidence, FDA approval, and Medicare NTAP status expand Infuse™ bone graft use in TLIF.

science

Sources

• T2The Next Evolution of TLIF: Where Innovation Meets Clinical EvidenceBioPharma Dive / Healthcare Dive / MedTech Dive28 Sept, 09:00